ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

0A4Y Aim Immunotech Inc

0.00
0.00 (0.00%)
- - 終了
15分遅延
名称 銘柄コード 市場 種別
Aim Immunotech Inc 0A4Y ロンドン Ordinary Share
  前日比 前日比 % 現在値 時刻
0.00 0.00% -
始値 安値 高値 終値 前日終値
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0921:50UKREGAIM ImmunoTech to Discuss First Quarter 2024 Financial..
2024/5/0621:30UKREGAIM ImmunoTech Completes cGMP Manufacturing of Clinical..
2024/4/2921:55UKREGAIM ImmunoTech Announces First Dose Level is Generally..
2024/4/1021:21UKREGAIM ImmunoTech Announces Positive Top-Line, Protocol-Planned..
2024/4/0220:30UKREGAIM ImmunoTech Reports Fourth Quarter and Full Year 2023..
2024/3/2622:05UKREGAIM ImmunoTech to Discuss Fourth Quarter and Full Year 2023..
2024/3/2522:05UKREGAIM ImmunoTech Announces Publication of Positive Findings..
2024/3/0722:45UKREGAIM ImmunoTech Announces Launch of CEO Corner Platform
2024/2/2922:45UKREGAIM ImmunoTech Outlines Recent Progress Across Clinical..
2024/2/1422:55UKREGAIM ImmunoTech Announces First Subject Dosed in the..
2024/1/2423:10GLOBEAIM ImmunoTech Receives Erasmus Medical Center Ethics Board..
2024/1/2222:55GLOBEAIM ImmunoTech Announces that the First Subject is Enrolled..
2024/1/1022:45GLOBEAIM ImmunoTech Announces Open Enrollment for Phase 1b/2..
2023/11/2723:05GLOBEAIM ImmunoTech Bolsters Intellectual Property Estate for..
2023/11/1521:30GLOBEAIM ImmunoTech Reports Third Quarter 2023 Financial Results..
2023/11/0922:05GLOBEAIM ImmunoTech to Discuss Third Quarter 2023 Financial..
2023/10/1721:45GLOBEAIM ImmunoTech Engages Business Development Firm, Azenova,..
2023/9/1202:00GLOBEAIM ImmunoTech Announces Report of Complete Topline Data..
2023/8/1519:45GLOBEAIM ImmunoTech Reports Second Quarter Financial Results and..
2023/8/0922:05GLOBEAIM ImmunoTech to Discuss Second Quarter 2023 Financial..
2023/8/0821:05GLOBEAIM ImmunoTech Announces Completion of Enrollment in Phase 2..
2023/7/1908:30GLOBEAIM ImmunoTech Issues Notice that an Unaffiliated Third..
2023/7/1021:05GLOBEAIM ImmunoTech Enrolls and Doses First Subject in Phase 2..
2023/6/2800:16GLOBEAIM ImmunoTech Announces Publication of Positive Findings..
2023/6/2721:45GLOBEAIM ImmunoTech Announces Authorizations from Competent..

最近閲覧した銘柄

Delayed Upgrade Clock